The authors found that Heller myotomy was the most effective treatment for achalasia in China and appeared safe and durable. The small number and very small sample sizes of controlled studies in the meta-analyses and their questionable quality means that these conclusions may not be reliable.
To evaluate the effectiveness of different treatments for achalasia in China.
Searching
The Chinese Biomedical Database and Chinese Scientific Journals Database were searched to March 2008. Search terms were reported.
Study selection
Controlled or uncontrolled studies of any form of treatment of achalasia were eligible for inclusion, provided that diagnosis was confirmed by clinical, manometric, radiographic and endoscopic means and that studies had more than 10 participants and at least 12 months' follow up. Outcomes of interest were symptom improvement at one year and treatment failure (defined as lack of improvement in symptom grade of at least 1, or recurrence of symptoms at one year).
The median age of participants ranged from 31 to 53 years; just over half were female. Interventions in the review included botulinum toxin (BoTx) injection of the lower oesophageal sphincter, pneumatic dilation, Heller myotomy, laparoscopic myotomy and/or thoracoscopic myotomy, with or without fundoplication. Response was defined as goodto-excellent response sustained to the end of the observation period without further therapy. Review outcomes included adverse effects. Duration of follow-up ranged from one to 178 months.
Two reviewers independently selected studies for inclusion.
Assessment of study quality
Study quality was evaluated using the Jadad scale, which assesses randomisation, blinding, and management of withdrawals and dropouts. Each study was awarded a score out of a maximum of 5 points. The authors did not state how the assessment was performed.
Data extraction
For controlled studies, risk ratios were calculated from the numbers of events in the two groups of each study, with 95% confidence intervals (CIs). For uncontrolled studies, event rates were extracted as percentages. Data on the type and number of adverse events in each study group were extracted. Two reviewers extracted the data.
Methods of synthesis
Data from controlled studies were combined to calculate pooled risk ratios and 95% CIs. Heterogeneity was assessed using the Χ 2 test and I 2 statistic. If I 2 was 50% or less, a fixed-effect model was used, otherwise a random-effects model was used. Data from uncontrolled studies were combined to calculate a pooled mean event rate weighted by sample size, with standard errors. Subgroup analysis was conducted to examine the effect of study design (controlled versus uncontrolled).
